Researchers Find Potential Way to Tweak Immune System to Help It Fight Tuberculosis

TB is the world’s second-deadliest infectious disease, behind COVID-19. A new BU-led study shows how to turn TB-susceptible immune cells into TB-resistant ones. Read more here:

Estimated costs for patients with tuberculosis in LMICs (Portnoy et al., 2023)

Check out the latest study by Portnoy et al. (2023) on the economic costs of tuberculosis treatment in low- and middle-income countries. The study delves into the often-overlooked financial burdens faced by patients, even in the presence of ostensibly free treatment. By synthesizing data from 22 national surveys conducted between 2015 and 2022, the authors […]

Portnoy et al. (2023) reveals economic potential of novel TB vaccines in low- and middle-income countries

Discover the potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries through a recently published modeling study in PLOS Medicine. In this study, Assistant Professor Allison Portnoy uncovers significant potential for these vaccines to drive substantial GDP gains, fostering economic development in LMICs. Read more about this exciting work […]

Providence/Boston Center for AIDS Research Awarded $9.2 Million NIH Renewal

The Providence/Boston Center for AIDS Research (Prov/Bos CFAR) has received a five-year $9.2 million award from the National Institutes of Health (NIH) to further its work promoting multi-disciplinary clinical, behavioral, translation, and basic science HIV research. Their research is particularly focused on marginalized populations including men who have sex with men (MSM), people who use […]

Portnoy et al. (2023) shows promise of novel TB vaccines for health equity in low-income and middle-income countries

Introducing a recently published paper in BMJ Global Health  by Assistant Professor Allison Portnoy titled “The Potential Impact of Novel Tuberculosis Vaccines on Health Equity and Financial Protection in Low-Income and Middle-Income Countries.” The study reveals that these vaccines can significantly reduce financial vulnerability and improve health outcomes, particularly for lower-income groups. Read more about […]